Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-move multicentre case control studies at primary care and hospital levels in Europe

I-MOVE/I-MOVE+ study team

Research output: Contribution to journalArticlepeer-review

Abstract

We measured early 2016/17 season influenza vaccine effectiveness (IVE) against influenza A(H3N2) in Europe using multicentre case control studies at primary care and hospital levels. IVE at primary care level was 44.1%, 46.9% and 23.4% among 0-14, 15-64 and ≥ 65 year-olds, and 25.7% in the influenza vaccination target group. At hospital level, IVE was 2.5%, 7.9% and 2.4% among ≥ 65, 65-79 and ≥ 80 year-olds. As in previous seasons, we observed suboptimal IVE against influenza A(H3N2).

Original languageEnglish
JournalEurosurveillance
Volume22
Issue number7
DOIs
Publication statusPublished - Feb 16 2017

ASJC Scopus subject areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health
  • Virology

Fingerprint Dive into the research topics of 'Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-move multicentre case control studies at primary care and hospital levels in Europe'. Together they form a unique fingerprint.

Cite this